Humana (NYSE:HUM) Sets New 1-Year High on Analyst Upgrade

Humana Inc. (NYSE:HUMGet Rating)’s share price hit a new 52-week high on Tuesday after Royal Bank of Canada raised their price target on the stock from $541.00 to $544.00. Royal Bank of Canada currently has an outperform rating on the stock. Humana traded as high as $511.30 and last traded at $504.61, with a volume of 5280 shares trading hands. The stock had previously closed at $501.07.

A number of other brokerages have also issued reports on HUM. Loop Capital assumed coverage on Humana in a research report on Thursday, June 16th. They set a “buy” rating and a $510.00 target price on the stock. Oppenheimer upped their price target on Humana from $520.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, September 16th. Morgan Stanley raised Humana from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $494.00 to $549.00 in a research report on Tuesday. Sanford C. Bernstein assumed coverage on Humana in a research report on Thursday, May 26th. They set a “market perform” rating and a $506.00 price target on the stock. Finally, SVB Leerink upped their target price on Humana from $535.00 to $540.00 and gave the stock an “outperform” rating in a research report on Thursday, July 28th. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $519.28.

Institutional Trading of Humana

Several hedge funds have recently added to or reduced their stakes in HUM. Riverview Trust Co acquired a new position in Humana in the 1st quarter valued at approximately $32,000. Transcend Capital Advisors LLC raised its holdings in Humana by 18.3% in the 1st quarter. Transcend Capital Advisors LLC now owns 587 shares of the insurance provider’s stock valued at $255,000 after acquiring an additional 91 shares in the last quarter. Krane Funds Advisors LLC raised its holdings in Humana by 4.2% in the 1st quarter. Krane Funds Advisors LLC now owns 889 shares of the insurance provider’s stock valued at $387,000 after acquiring an additional 36 shares in the last quarter. CCLA Investment Management Ltd raised its holdings in Humana by 1.4% in the 1st quarter. CCLA Investment Management Ltd now owns 218,232 shares of the insurance provider’s stock valued at $95,075,000 after acquiring an additional 3,034 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in Humana in the 1st quarter valued at approximately $800,000. Institutional investors own 93.50% of the company’s stock.

Humana Stock Performance

The firm has a fifty day simple moving average of $486.51 and a 200 day simple moving average of $460.00. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.73. The stock has a market cap of $63.64 billion, a price-to-earnings ratio of 20.53, a PEG ratio of 1.49 and a beta of 0.77.

Humana (NYSE:HUMGet Rating) last posted its quarterly earnings results on Wednesday, July 27th. The insurance provider reported $8.67 EPS for the quarter, beating the consensus estimate of $7.67 by $1.00. Humana had a return on equity of 18.42% and a net margin of 3.52%. The firm had revenue of $23.66 billion during the quarter, compared to analysts’ expectations of $23.44 billion. During the same quarter in the prior year, the firm posted $6.89 EPS. The company’s revenue for the quarter was up 14.6% on a year-over-year basis. As a group, sell-side analysts expect that Humana Inc. will post 25.04 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a $0.7875 dividend. The ex-dividend date of this dividend is Thursday, September 29th. This represents a $3.15 dividend on an annualized basis and a dividend yield of 0.63%. Humana’s payout ratio is presently 12.86%.

Humana Company Profile

(Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.